CORONAVIRUS DISEASE 2019
Clinical trials for CORONAVIRUS DISEASE 2019 explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS DISEASE 2019 trials appear
Sign up with your email to follow new studies for CORONAVIRUS DISEASE 2019, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heartburn and arthritis drugs tested against COVID-19
Disease control CompletedThis Phase 2 trial tested whether combining famotidine (Pepcid) and celecoxib (Celebrex) could help people with COVID-19 recover faster. Only 4 participants were enrolled, making it too small to draw firm conclusions. The study aimed to see if these drugs could reduce symptom sev…
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental drug leronlimab tested in 484 severe COVID-19 patients
Disease control CompletedThis study tested a drug called leronlimab in 484 hospitalized adults with severe or critical COVID-19. Participants received weekly injections of the drug or a placebo to see if it could lower the risk of death and improve recovery. The trial is now complete, and results help un…
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Scientists probe COVID-19's attack on immune cells
Knowledge-focused CompletedThis study looked at how the virus that causes COVID-19 reduces the number of infection-fighting white blood cells (lymphocytes) in the blood. Researchers collected blood samples and medical records from 240 adults with or recovering from COVID-19. The goal was to learn more abou…
Matched conditions: CORONAVIRUS DISEASE 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC